Mammograms are commonly used to screen for breast cancer. In spite of easy access, conventional mammograms cannot find every tumor due to the limited image contrast mechanism. The measurement of X-ray beam refraction in breast tissues has the potential to be the next…
Read More
Drug target for aggressive breast cancer found
A team of British and American scientists have discovered a way to slow the growth of breast cancer stem cells in the lab. The study led by Dr. Bruno Simões and Professor Rob Clarke from The University of Manchester could…
Read More
Here’s how immune system treatment to reduce stress can prevent cancer metastases
A new approach from Tel Aviv University can save the lives of cancer patients! Researchers have found that the short time period around tumour removal surgery (the weeks before and after surgery) is critical for the prevention of metastases development,…
Read More
Novel therapeutic approaches for aggressive bone cancer
Osteosarcoma (OS) is the most common form of aggressive bone cancer. A MedUni Vienna study led by geneticist Erwin Wagner has uncovered new insights into the disease mechanisms of OS, paving the way for potential new diagnostic and treatment strategies…
Read More
Researchers identify possible drug target for prostate cancer
Researchers from Boston University School of Medicine (BUSM) have discovered that the protein BRD4 could be an important new target to prevent castration-resistant prostate cancer metastases. Castration-resistant prostate cancer is a highly aggressive form of prostate cancer that often leads…
Read More
Major study shows prostate cancer treatment has significant impact on quality of life
Findings from the first international prostate cancer quality of life study conducted by patients themselves reports that significant numbers of men treated for the disease are struggling with continence and sexual problems after treatment. Results suggest that any treatment apart…
Read More
Boosting immune memory could reduce cancer recurrence
Blocking a newly identified “immune memory checkpoint” in immune cells could improve immunotherapy and help prevent cancers from recurring, according to new findings in mice and human samples by researchers at the UPMC Hillman Cancer Center and the University of…
Read More
New therapy extends breast cancer survival rate, prevents reoccurrence
A new immunotherapy developed by researchers at Northwestern University dramatically extends the survival time of mice with triple negative breast cancer, one of the most aggressive and difficult-to-treat forms of breast cancer. In a new study, mice treated with the…
Read More
Study: The immune effects of seclidemstat in aggressive ovarian cancer striking young women
A drug known as SP-2577 could help enable the body’s own immune system to attack ovarian cancer, according to a study led by the Translational Genomics Research Institute (TGen), an affiliate of City of Hope. Published today in the scientific…
Read More
New treatment for rare blood cancer approved for NHS use in England
The National Institute for Health and Care Excellence (NICE) has approved the drug brentuximab vedotin to treat some adults with a rare type of fast-growing lymphoma. Clinical trial data suggests that combining the targeted treatment with chemotherapy could give people…
Read More